These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Parosteal osteogenic sarcoma of bone with coexistent low- and high-grade sarcomatous components. Pintado SO; Lane J; Huvos AG Hum Pathol; 1989 May; 20(5):488-91. PubMed ID: 2707799 [TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. Bacci G; Ferrari S; Bertoni F; Rimondini S; Longhi A; Bacchini P; Forni C; Manfrini M; Donati D; Picci P J Clin Oncol; 2000 Jan; 18(1):4-11. PubMed ID: 10623687 [TBL] [Abstract][Full Text] [Related]
26. Outcome of Ewing sarcoma in children and adolescents with Ewing sarcoma: a five-year survival from a single institution. Zawitkowska-Klaczyńska J; Drabko K; Katski K; Wozniak M; Kowalczyk JR Pediatr Hematol Oncol; 2004; 21(7):627-33. PubMed ID: 15626019 [TBL] [Abstract][Full Text] [Related]
27. Primary dedifferentiated parosteal osteosarcoma in a 21-year-old man. Johnson JS; Mayerson JL Am J Orthop (Belle Mead NJ); 2011 Sep; 40(9):E182-5. PubMed ID: 22022683 [No Abstract] [Full Text] [Related]
28. Metastatic Ewing sarcoma/PNET of bone at diagnosis: prognostic factors--a report from Saudi Arabia. Jenkin RD; Al-Fawaz I; Al-Shabanah MO; Allam A; Ayas M; Memon M; Rifai S; Schultz HP Med Pediatr Oncol; 2001 Oct; 37(4):383-9. PubMed ID: 11568903 [TBL] [Abstract][Full Text] [Related]
29. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822 [TBL] [Abstract][Full Text] [Related]
30. Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapy. Kreyer J; Ranft A; Timmermann B; Juergens H; Jung S; Wiebe K; Boelling T; Schuck A; Vieth V; Streitbuerger A; Hardes J; Heinemann M; Dirksen U Pediatr Blood Cancer; 2018 Dec; 65(12):e27384. PubMed ID: 30084137 [TBL] [Abstract][Full Text] [Related]
31. Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma. Scobioala S; Ranft A; Wolters H; Jabar S; Paulussen M; Timmermann B; Juergens H; Hassenpflug W; Klingebiel T; Elsayad K; Eich HT; Dirksen U Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):584-592. PubMed ID: 30244879 [TBL] [Abstract][Full Text] [Related]
32. Primary Ewing Family of Tumors of the Jaw Has a Better Prognosis Compared to Tumors of Extragnathic Sites. Owosho AA; Ko E; Rosenberg HI; Yom SK; Antonescu CR; Huryn JM; Estilo CL J Oral Maxillofac Surg; 2016 May; 74(5):973-81. PubMed ID: 26679553 [TBL] [Abstract][Full Text] [Related]
33. Juxtacortical osteosarcoma. A distinct malignant bone neoplasm. Anthouli-Anagnostopoulou FA; Hatziolou E; Papachristou G; Demoula I Adv Clin Path; 2000 Jul; 4(3):127-31. PubMed ID: 11080792 [TBL] [Abstract][Full Text] [Related]
34. Pediatric Ewing sarcoma of the head and neck: A retrospective survival analysis. Martin E; Radomski S; Harley EH Int J Pediatr Otorhinolaryngol; 2019 Feb; 117():138-142. PubMed ID: 30579068 [TBL] [Abstract][Full Text] [Related]
35. A Review of Ewing Sarcoma Treatment: Is it Still a Subject of Debate? Kridis WB; Toumi N; Chaari H; Khanfir A; Ayadi K; Keskes H; Boudawara T; Daoud J; Frikha M Rev Recent Clin Trials; 2017; 12(1):19-23. PubMed ID: 28117008 [TBL] [Abstract][Full Text] [Related]
36. Ewing sarcoma, analysis of survival at 6 years with multidisciplinary therapy. Borrego-Paredes E; Prada-Chamorro E; Chacón-Cartaya S; Santos-Rodas A; Gallo-Ayala JM; Hernández-Beneit JM Rev Esp Cir Ortop Traumatol (Engl Ed); 2019; 63(2):86-94. PubMed ID: 30642764 [TBL] [Abstract][Full Text] [Related]
37. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology. Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567 [TBL] [Abstract][Full Text] [Related]
38. Clinical Features and Long-Term Outcome of Primary Intracranial Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors: 14 Cases From a Single Institution. Chen J; Jiang Q; Zhang Y; Yu Y; Zheng Y; Chen J; Zhao Y; Miao Z; Fan F; Wang Y World Neurosurg; 2019 Feb; 122():e1606-e1614. PubMed ID: 30496933 [TBL] [Abstract][Full Text] [Related]
39. BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma. Puls F; Niblett A; Marland G; Gaston CL; Douis H; Mangham DC; Sumathi VP; Kindblom LG Am J Surg Pathol; 2014 Oct; 38(10):1307-18. PubMed ID: 24805859 [TBL] [Abstract][Full Text] [Related]
40. Prognostic and therapeutic factors influencing the clinical outcome of metastatic Ewing sarcoma family of tumors: A retrospective report from the Japan Ewing Sarcoma Study Group. Umeda K; Miyamura T; Yamada K; Sano H; Hosono A; Sumi M; Okita H; Kamio T; Maeda N; Fujisaki H; Jyoko R; Watanabe A; Hosoya Y; Hasegawa D; Takenaka S; Nakagawa S; Chin M; Ozaki T; Pediatr Blood Cancer; 2021 Mar; 68(3):e28844. PubMed ID: 33340261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]